LIfe Extension   Report issue

Foundation Phase 1
Founded: Fort Lauderdale FL United States (1980)

Organization Overview

First Clinical Trial
2010
NCT01716637
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

LIfe Extension | Life Extension Foundation Inc.